173 related articles for article (PubMed ID: 33503866)
1. Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease.
Ghelardi A; Marrai R; Bogani G; Sopracordevole F; Bay P; Tonetti A; Lombardi S; Bertacca G; Joura EA
Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33503866
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study.
Casajuana-Pérez A; Ramírez-Mena M; Ruipérez-Pacheco E; Gil-Prados I; García-Santos J; Bellón-Del Amo M; Hernández-Aguado JJ; de la Fuente-Valero J; Zapardiel I; Coronado-Martín PJ
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214747
[No Abstract] [Full Text] [Related]
3. Efficacy of HPV Vaccination Regarding Vulvar and Vaginal Recurrences in Previously Treated Women: The Need for Further Evidence.
Bechini A; Moscadelli A; Velpini B; Bonito B; Orlando P; Putignano P; Posi S; Stacchini L; Bonanni P; Boccalini S
Vaccines (Basel); 2023 Jun; 11(6):. PubMed ID: 37376473
[TBL] [Abstract][Full Text] [Related]
4. Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol.
Stankiewicz Karita HC; Hauge K; Magaret A; Mao C; Schouten J; Grieco V; Xi LF; Galloway DA; Madeleine MM; Wald A
JAMA Netw Open; 2019 Apr; 2(4):e190819. PubMed ID: 30977845
[TBL] [Abstract][Full Text] [Related]
5. Vulvar High-Grade Squamous Intraepithelial Lesions Treated with Imiquimod: Can Persistence of Human Papillomavirus Predict Recurrence?
Fernández-Montolí ME; Heydari F; Lavecchia F; Pavón MÂ; Guerra E; Matias-Guiu X; Marti MD; Tous S
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230731
[No Abstract] [Full Text] [Related]
6. HPV Vaccination as Adjuvant to Conization in Women with Cervical Intraepithelial Neoplasia: A Study under Real-Life Conditions.
Del Pino M; Martí C; Torras I; Henere C; Munmany M; Marimon L; Saco A; Torné A; Ordi J
Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32456136
[No Abstract] [Full Text] [Related]
7. HPV Vaccination in Women with Cervical Intraepithelial Neoplasia Undergoing Excisional Treatment: Insights into Unsolved Questions.
Henere C; Torné A; Llupià A; Aldea M; Martí C; Glickman A; Saco A; Marimon L; Manzotti C; Rakislova N; Ordi J; Del Pino M
Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746495
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years.
Hidalgo-Tenorio C; Pasquau J; Omar-Mohamed M; Sampedro A; López-Ruz MA; López Hidalgo J; Ramírez-Taboada J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498165
[TBL] [Abstract][Full Text] [Related]
9. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
10. HPV-independent Precursors Mimicking High-grade Squamous Intraepithelial Lesions (HSIL) of the Vulva.
Rakislova N; Alemany L; Clavero O; Del Pino M; Saco A; Marimon L; Quirós B; Lloveras B; Ribera-Cortada I; Alejo M; Pawlita M; Quint W; de Sanjose S; Ordi J;
Am J Surg Pathol; 2020 Nov; 44(11):1506-1514. PubMed ID: 32657782
[TBL] [Abstract][Full Text] [Related]
11. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Essahsah F; Fathers LM; Offringa R; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; van der Burg SH; Melief CJ
N Engl J Med; 2009 Nov; 361(19):1838-47. PubMed ID: 19890126
[TBL] [Abstract][Full Text] [Related]
12. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
Hidalgo-Tenorio C; Ramírez-Taboada J; Gil-Anguita C; Esquivias J; Omar-Mohamed-Balgahata M; SamPedro A; Lopez-Ruz M; Pasquau J
AIDS Res Ther; 2017 Jul; 14(1):34. PubMed ID: 28720147
[TBL] [Abstract][Full Text] [Related]
14. An investigation into human papillomavirus (HPV) vaccination for patients undergoing surgery for high-grade cervical or vulvar dysplasia.
Boyles GP; Baek J; Pandit R; Cosgrove CM; Bixel KL
Gynecol Oncol Rep; 2022 Jun; 41():101001. PubMed ID: 35603128
[TBL] [Abstract][Full Text] [Related]
15. HPV Vaccination after Primary Treatment of HPV-Related Disease across Different Organ Sites: A Multidisciplinary Comprehensive Review and Meta-Analysis.
Di Donato V; Caruso G; Bogani G; Cavallari EN; Palaia G; Perniola G; Ralli M; Sorrenti S; Romeo U; Pernazza A; Pierangeli A; Clementi I; Mingoli A; Cassoni A; Tanzi F; Cuccu I; Recine N; Mancino P; de Vincentiis M; Valentini V; d'Ettorre G; Della Rocca C; Mastroianni CM; Antonelli G; Polimeni A; Muzii L; Palaia I
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214697
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females.
Hofstetter AM; Ompad DC; Stockwell MS; Rosenthal SL; Soren K
JAMA Pediatr; 2016 May; 170(5):445-52. PubMed ID: 26974250
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.
Garland SM; Joura EA; Ault KA; Bosch FX; Brown DR; Castellsagué X; Ferenczy A; Ferris DG; Giuliano AR; Hernandez-Avila M; Huh WK; Iversen OE; Kjaer SK; Kurman RJ; Luna J; Monsonego J; Muñoz N; Paavonen J; Pitisuttihum P; Ronnett BM; Steben M; Stoler MH; Wheeler CM; Wiley DJ; Perez G; Saah AJ; Luxembourg A; Li S; DiNubile MJ; Wagner M; Velicer C
Obstet Gynecol; 2018 Aug; 132(2):261-270. PubMed ID: 29995724
[TBL] [Abstract][Full Text] [Related]
18. Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women.
Aro K; Nieminen P; Louvanto K; Jakobsson M; Virtanen S; Lehtinen M; Dillner J; Kalliala I
Gynecol Oncol; 2019 Aug; 154(2):354-359. PubMed ID: 31176553
[TBL] [Abstract][Full Text] [Related]
19. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
20. Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect.
Han L; Zhang B
Infect Agent Cancer; 2023 Oct; 18(1):66. PubMed ID: 37898754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
